These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22060158)

  • 1. Inhibition of glutaminyl cyclase attenuates cell migration modulated by monocyte chemoattractant proteins.
    Chen YL; Huang KF; Kuo WC; Lo YC; Lee YM; Wang AH
    Biochem J; 2012 Mar; 442(2):403-12. PubMed ID: 22060158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of glutaminyl cyclase prevents pGlu-Abeta formation after intracortical/hippocampal microinjection in vivo/in situ.
    Schilling S; Appl T; Hoffmann T; Cynis H; Schulz K; Jagla W; Friedrich D; Wermann M; Buchholz M; Heiser U; von Hörsten S; Demuth HU
    J Neurochem; 2008 Aug; 106(3):1225-36. PubMed ID: 18627432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloidogenic processing of amyloid precursor protein: evidence of a pivotal role of glutaminyl cyclase in generation of pyroglutamate-modified amyloid-beta.
    Cynis H; Scheel E; Saido TC; Schilling S; Demuth HU
    Biochemistry; 2008 Jul; 47(28):7405-13. PubMed ID: 18570439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutaminyl cyclase in human cortex: correlation with (pGlu)-amyloid-β load and cognitive decline in Alzheimer's disease.
    Morawski M; Schilling S; Kreuzberger M; Waniek A; Jäger C; Koch B; Cynis H; Kehlen A; Arendt T; Hartlage-Rübsamen M; Demuth HU; Roßner S
    J Alzheimers Dis; 2014; 39(2):385-400. PubMed ID: 24164736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal pyroglutamate formation in CX3CL1 is essential for its full biologic activity.
    Kehlen A; Haegele M; Böhme L; Cynis H; Hoffmann T; Demuth HU
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28739588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structures of glutaminyl cyclases (QCs) from Drosophila melanogaster reveal active site conservation between insect and mammalian QCs.
    Koch B; Kolenko P; Buchholz M; Carrillo DR; Parthier C; Wermann M; Rahfeld JU; Reuter G; Schilling S; Stubbs MT; Demuth HU
    Biochemistry; 2012 Sep; 51(37):7383-92. PubMed ID: 22897232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV.
    Van Coillie E; Proost P; Van Aelst I; Struyf S; Polfliet M; De Meester I; Harvey DJ; Van Damme J; Opdenakker G
    Biochemistry; 1998 Sep; 37(36):12672-80. PubMed ID: 9730840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of glutaminyl cyclase alters pyroglutamate formation in mammalian cells.
    Cynis H; Schilling S; Bodnár M; Hoffmann T; Heiser U; Saido TC; Demuth HU
    Biochim Biophys Acta; 2006 Oct; 1764(10):1618-25. PubMed ID: 17005457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing secondary glutaminyl cyclase (QC) inhibitor interactions applying an in silico-modeling/site-directed mutagenesis approach: implications for drug development.
    Koch B; Buchholz M; Wermann M; Heiser U; Schilling S; Demuth HU
    Chem Biol Drug Des; 2012 Dec; 80(6):937-46. PubMed ID: 22967026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure and functional analysis of the glutaminyl cyclase from Xanthomonas campestris.
    Huang WL; Wang YR; Ko TP; Chia CY; Huang KF; Wang AH
    J Mol Biol; 2010 Aug; 401(3):374-88. PubMed ID: 20558177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutaminyl cyclase activity is a characteristic feature of human cerebrospinal fluid.
    Gontsarova A; Kaufmann E; Tumani H; Dressel A; Mandel F; Wiesmüller KH; Kunert-Keil C; Brinkmeier H
    Clin Chim Acta; 2008 Mar; 389(1-2):152-9. PubMed ID: 18187042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures of glycosylated mammalian glutaminyl cyclases reveal conformational variability near the active center.
    Ruiz-Carrillo D; Koch B; Parthier C; Wermann M; Dambe T; Buchholz M; Ludwig HH; Heiser U; Rahfeld JU; Stubbs MT; Schilling S; Demuth HU
    Biochemistry; 2011 Jul; 50(28):6280-8. PubMed ID: 21671571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Potent Human Glutaminyl Cyclase Inhibitors as Anti-Alzheimer's Agents Based on Rational Design.
    Hoang VH; Tran PT; Cui M; Ngo VT; Ann J; Park J; Lee J; Choi K; Cho H; Kim H; Ha HJ; Hong HS; Choi S; Kim YH; Lee J
    J Med Chem; 2017 Mar; 60(6):2573-2590. PubMed ID: 28234463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Glutaminyl Cyclases alleviates CCL2-mediated inflammation of non-alcoholic fatty liver disease in mice.
    Cynis H; Kehlen A; Haegele M; Hoffmann T; Heiser U; Fujii M; Shibazaki Y; Yoneyama H; Schilling S; Demuth HU
    Int J Exp Pathol; 2013 Jun; 94(3):217-25. PubMed ID: 23560443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship of human glutaminyl cyclase inhibitors having an N-(5-methyl-1H-imidazol-1-yl)propyl thiourea template.
    Tran PT; Hoang VH; Thorat SA; Kim SE; Ann J; Chang YJ; Nam DW; Song H; Mook-Jung I; Lee J; Lee J
    Bioorg Med Chem; 2013 Jul; 21(13):3821-30. PubMed ID: 23643900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning, expression, characterization, and crystallization of a glutaminyl cyclase from human bone marrow: a single zinc metalloenzyme.
    Huang KF; Liu YL; Wang AH
    Protein Expr Purif; 2005 Sep; 43(1):65-72. PubMed ID: 16084398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human glutaminyl cyclase: Structure, function, inhibitors and involvement in Alzheimer's disease.
    Vijayan DK; Zhang KYJ
    Pharmacol Res; 2019 Sep; 147():104342. PubMed ID: 31288079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutaminyl cyclases from animals and plants: a case of functionally convergent protein evolution.
    Schilling S; Wasternack C; Demuth HU
    Biol Chem; 2008 Aug; 389(8):983-91. PubMed ID: 18979624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linked production of pyroglutamate-modified proteins via self-cleavage of fusion tags with TEV protease and autonomous N-terminal cyclization with glutaminyl cyclase in vivo.
    Shih YP; Chou CC; Chen YL; Huang KF; Wang AH
    PLoS One; 2014; 9(4):e94812. PubMed ID: 24733552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3.
    Garcia-Zepeda EA; Combadiere C; Rothenberg ME; Sarafi MN; Lavigne F; Hamid Q; Murphy PM; Luster AD
    J Immunol; 1996 Dec; 157(12):5613-26. PubMed ID: 8955214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.